Iew. Am J Surg Pathol , :-.Ward C, Lucas M, Piris
Iew. Am J Surg Pathol , :-.Ward C, Lucas M, Piris J, Collier J, Chapel H: Abnormal liver function in widespread variable immunodeficiency issues on account of nodular regenerative hyperplasia. Clin Exp Immunol , :-.Malamut G, Ziol M, Suarez F, Beaugrand M, Viallard JF, Lascaux AS, Verkarre V, Bechade D, Poynard T, Hermine O, Cellier C: Nodular regenerativehyperplasia: the main liver PubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/26622447?dopt=Abstract disease in patients with key hypogammaglobulinemia and hepatic abnormalities. J Hepatol , :-. Boileau J, Mouillot G, Gerard L, Carmagnat M, Rabian C, Oksenhendler E, Pasquali JL, Korganow AS: Autoimmunity in widespread variable immunodeficiency: correlation with lymphocyte phenotype within the French DEFI study. J Autoimmun , :-. Quinti I, Soresina A, Spadaro G, Martino S, Donnanno S, Agostini C, Claudio P, GSK2269557 (free base) chemical information Franco D, Maria Pesce A, Borghese F, Guerra A, Rondelli R, Plebani A; Italian Key Immunodeficiency Network: Long-term follow-up and outcome of a sizable cohort of individuals with popular variable immunodeficiency. J Clin Immunol , :-. S e P, Bourdillon L, Sarrot-Reynauld F, Ruivard M, Jaussaud R, Bouhour D, Bonotte B, Gardembas M, Poindron V, Thiercelin MF, Broussolle C, Oksenhendler E; DEF-I Study Group: Autoimmune hemolytic anemia and common variable immunodeficiency: a case-control study of individuals. Medicine (Baltimore) , :-. Mouillot G, Carmagnat M, G ard L, Garnier JL, Fieschi C, Vince N, Karlin L, Viallard JF, Jaussaud R, Boileau J, Donadieu J, Gardembas M, Schleinitz N, Suarez F, Hachulla E, Delavigne K, Morisset M, Jacquot S, Just N, Galicier L, Charron D, DebrP, Oksenhendler E, Rabian C; DEFI Study Group: B-cell and T-cell phenotypes in CVID sufferers correlate using the clinical phenotype from the illness. J Clin Immunol , :-. Sander CA, Medeiros LJ, Weiss LM, Yano T, Sneller MC, Jaffe ES: Lymphoproliferative lesions in patients with common variable immunodeficiency syndrome. Am J Surg Pathol , :-. Mellemkjaer L, Hammarstrom L, Andersen V, Yuen J, Heilmann C, Barington T, Bjorkander J, Olsen JH: Cancer threat among individuals with IgA deficiency or frequent variable immunodeficiency and their relatives: a combined Danish and Swedish study. Clin Exp Immunol , :-. Vorechovsky I, Scott D, Haeney MR, Webster DA: Chromosomal radiosensitivity in frequent variable immune deficiency. Mutat Res , :-. Seymour B, Miles J, Haeney M: Key antibody deficiency and diagnostic delay. J Clin Pathol , :-. Rizzi M, Neumann C, Fielding AK, Marks R, Goldacker S, Thaventhiran J, Tarzi MD, Schlesier M, Salzer U, Eibel H, Warnatz K, Finke J, Grimbacher B, Peter HH: Outcome of allogeneic stem cell transplantation in adults with frequent variable immunodeficiency. J Allergy Clin Immunol , :-.e. Ballow M: Immunoglobulin therapy: procedures of delivery. J Allergy Clin Immunol , :-. Gardulf A: Immunoglobulin therapy for key antibody deficiencies: positive aspects from the subcutaneous route. BioDrugs , :-. Gardulf A, Andersen V, Bjorkander J, Ericson D, Froland SS, Gustafson R, Hammarstrom L, Jacobsen MB, Jonsson E, Moller G, et al.: Subcutaneous immunoglobulin replacement in sufferers with primary antibody deficiencies: safety and charges. Lancet , :-. Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP Jr, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C; Primary Immunodeficiency Committee on the American Academy of Allergy, Asthma and Immunology: Use of intravenous immunoglobulin in human illness: a evaluation of proof.

Leave a Reply